Researchers have revealed a novel mechanism by which the chromatin remodeler brahma-related gene 1 (Brg1) regulates Group 2 ...
Just days after gaining similar regulatory approval in the USA, AstraZeneca and Amgen’s Tezspire (tezepelumab) has been ...
Drugmaker AstraZeneca said on Wednesday that its chronic rhinosinusitis with nasal polyps treatment, Tezspire, has been ...
The human respiratory system is designed with remarkable efficiency to filter, humidify, and warm the air we breathe. However ...
An annual crisis in Delhi-NCR between October and February, the heavy smog caused by air pollution exacts a devastating toll ...
Promised as a beacon of progress and development, the decade-old Sahiwal coal-fired power plant has led to displacement, ...
However, Amgen still expects decent top-line growth for the year. Its revenue guidance of $35.5 billion at the midpoint implies a revenue increase of 6.3% compared to 2024, a respectable performance ...
The Canadian Medical Association (CMA) wishes to remind the Quebec government of the potential consequences of Bill 2, which was tabled and adopted by the Quebec National Assembly to end negotiations ...
Foods that may hurt your gut health include ultra-processed and high-fat foods, red meat, artificial sweeteners, alcohol, and ...
RAPT Therapeutics, Inc. ( NASDAQ: RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria October 20, 2025 8:30 AM EDT Good morning, and welcome to RAPT's conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback